Enhanced Prior Authorization for Drugs – No longer optional for plan sponsors


Over the last two years, there has been a significant change to the pharmaceutical benefits landscape due to an increase in specialty drugs entering the market. Although they impact approximately only 2% of claimants, the number of specialty drugs is growing and they contribute significantly to the share of total drug cost under an employee [...]